Skip to main content
Erschienen in: Dysphagia 1/2022

12.02.2021 | Original Article

Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis

verfasst von: Mahdi Barzegar, Omid Mirmosayeb, Mina Rezaei, Geir Bjørklund, Nasim Nehzat, Alireza Afshari-Safavi, Vahid Shaygannejad

Erschienen in: Dysphagia | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Dysphagia is one of the most common symptoms in multiple sclerosis (MS) patients. It can reduce the quality of life and increase the risk of mortality by developing complications such as aspiration pneumonia. The present study was conducted to estimate the prevalence of dysphagia in MS patients and investigate the associations between dysphagia and disease characteristics. The Persian version of the DYMUS questionnaire was used to assess dysphagia in 865 patients with MS, including 738 (85.3%) relapsing–remitting MS (RRMS), 106 (12.3%) secondary progressive MS (SPMS), and 21 (2.4%) primary progressive MS (PPMS). Also, demographic and clinical data, including age, sex, smoking status, Expanded Disability Status Scale (EDSS) score, disease duration, disease-modifying therapies exposure, initial symptoms of MS, were recorded. The mean (SD) age was 37.95(9.25) years, and 83.1% of the participants were female. The prevalence of dysphagia was estimated to be 25.4% among all patients. According to the DYMUS questionnaire results, the prevalence of dysphagia in RRMS, SPMS, and PPMS patients was 22.2%, 44.3%, and 42.9%, respectively. After multivariate analysis the current EDSS score (OR = 1.197, CI: 1.062, 1.350, p = 0.003), cerebellar impairment (OR = 1.335, CI: 1.450, 4.716, p = 0.004) and motor dysfunction (OR = 1.651, CI: 1.004, 2.715, p = 0.048) emerged as the risk factors for dysphagia. Since dysphagia, as previously mentioned, is a common symptom in multiple sclerosis, particularly in SPMS and PPMS courses, active screening for this condition is recommended in all patients, particularly those with identified risk factors.
Literatur
2.
Zurück zum Zitat Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintore M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73. https://doi.org/10.1016/S1474-4422(17)30470-2.CrossRefPubMed Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintore M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73. https://​doi.​org/​10.​1016/​S1474-4422(17)30470-2.CrossRefPubMed
3.
Zurück zum Zitat Mirmosayyeb O, Brand S, Barzegar M, Afshari-Safavi A, Nehzat N, Shaygannejad V, Sadeghi Bahmani D. Clinical characteristics and disability progression of early-and late-onset multiple sclerosis compared to adult-onset multiple sclerosis. J Clin Med. 2020;9(5):1326.CrossRef Mirmosayyeb O, Brand S, Barzegar M, Afshari-Safavi A, Nehzat N, Shaygannejad V, Sadeghi Bahmani D. Clinical characteristics and disability progression of early-and late-onset multiple sclerosis compared to adult-onset multiple sclerosis. J Clin Med. 2020;9(5):1326.CrossRef
4.
Zurück zum Zitat Mirmosayyeb O, Badihian S, Manouchehri N, Basiri AK, Barzegar M, Esmaeil N, Fayyazi E, Shaygannejad V. The interplay of multiple sclerosis and menstrual cycle: which one affects the other one? Mult Scler Relat Disord. 2018;21:46–50.CrossRef Mirmosayyeb O, Badihian S, Manouchehri N, Basiri AK, Barzegar M, Esmaeil N, Fayyazi E, Shaygannejad V. The interplay of multiple sclerosis and menstrual cycle: which one affects the other one? Mult Scler Relat Disord. 2018;21:46–50.CrossRef
6.
Zurück zum Zitat Sasegbon A, Hamdy S. The anatomy and physiology of normal and abnormal swallowing in oropharyngeal dysphagia. Neurogastroenterol Motil. 2017;29(11):e13100.CrossRef Sasegbon A, Hamdy S. The anatomy and physiology of normal and abnormal swallowing in oropharyngeal dysphagia. Neurogastroenterol Motil. 2017;29(11):e13100.CrossRef
7.
Zurück zum Zitat Daniels SK, Huckabee M-L, Gozdzikowska K. Dysphagia following stroke. Clinical Dysphagia. 3rd ed. San Diego: Plural Publishing; 2019. Daniels SK, Huckabee M-L, Gozdzikowska K. Dysphagia following stroke. Clinical Dysphagia. 3rd ed. San Diego: Plural Publishing; 2019.
11.
Zurück zum Zitat Marchese-Ragona R, Restivo D, Marioni G, Ottaviano G, Masiero S, Staffieri A. Evaluation of swallowing disorders in multiple sclerosis. Neurol Sci. 2006;27(4):s335–7.CrossRef Marchese-Ragona R, Restivo D, Marioni G, Ottaviano G, Masiero S, Staffieri A. Evaluation of swallowing disorders in multiple sclerosis. Neurol Sci. 2006;27(4):s335–7.CrossRef
13.
Zurück zum Zitat Jean A. Brain stem control of swallowing: neuronal network and cellular mechanisms. Physiol Rev. 2001;81(2):929–69.CrossRef Jean A. Brain stem control of swallowing: neuronal network and cellular mechanisms. Physiol Rev. 2001;81(2):929–69.CrossRef
14.
Zurück zum Zitat Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N, Geurts JJG, Paul F, Reich DS, Toosy AT, Traboulsee A, Wattjes MP, Yousry TA, Gass A, Lubetzki C, Weinshenker BG, Rocca MA. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain. 2019;142(7):1858–75. https://doi.org/10.1093/brain/awz144.CrossRefPubMedPubMedCentral Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N, Geurts JJG, Paul F, Reich DS, Toosy AT, Traboulsee A, Wattjes MP, Yousry TA, Gass A, Lubetzki C, Weinshenker BG, Rocca MA. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain. 2019;142(7):1858–75. https://​doi.​org/​10.​1093/​brain/​awz144.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Solaro C, Rezzani C, Trabucco E, Amato M, Zipoli V, Portaccio E, Giannini M, Patti F, D’Amico E, Frau J. Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). J Neurol Sci. 2013;331(1–2):94–7.CrossRef Solaro C, Rezzani C, Trabucco E, Amato M, Zipoli V, Portaccio E, Giannini M, Patti F, D’Amico E, Frau J. Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). J Neurol Sci. 2013;331(1–2):94–7.CrossRef
18.
Zurück zum Zitat Poorjavad M, Derakhshandeh F, Etemadifar M, Soleymani B, Minagar A, Maghzi A-H. Oropharyngeal dysphagia in multiple sclerosis. Mult Scler. 2010;16(3):362–5.CrossRef Poorjavad M, Derakhshandeh F, Etemadifar M, Soleymani B, Minagar A, Maghzi A-H. Oropharyngeal dysphagia in multiple sclerosis. Mult Scler. 2010;16(3):362–5.CrossRef
20.
Zurück zum Zitat Lorscheider J, Buzzard K, Jokubaitis V, Spelman T, Havrdova E, Horakova D, Trojano M, Izquierdo G, Girard M, Duquette P, Prat A, Lugaresi A, Grand’Maison F, Grammond P, Hupperts R, Alroughani R, Sola P, Boz C, Pucci E, Lechner-Scott J, Bergamaschi R, Oreja-Guevara C, Iuliano G, Van Pesch V, Granella F, Ramo-Tello C, Spitaleri D, Petersen T, Slee M, Verheul F, Ampapa R, Amato MP, McCombe P, Vucic S, Sanchez Menoyo JL, Cristiano E, Barnett MH, Hodgkinson S, Olascoaga J, Saladino ML, Gray O, Shaw C, Moore F, Butzkueven H, Kalincik T, Group MSS. Defining secondary progressive multiple sclerosis. Brain. 2016;139(Pt 9):2395–405. https://doi.org/10.1093/brain/aww173.CrossRefPubMed Lorscheider J, Buzzard K, Jokubaitis V, Spelman T, Havrdova E, Horakova D, Trojano M, Izquierdo G, Girard M, Duquette P, Prat A, Lugaresi A, Grand’Maison F, Grammond P, Hupperts R, Alroughani R, Sola P, Boz C, Pucci E, Lechner-Scott J, Bergamaschi R, Oreja-Guevara C, Iuliano G, Van Pesch V, Granella F, Ramo-Tello C, Spitaleri D, Petersen T, Slee M, Verheul F, Ampapa R, Amato MP, McCombe P, Vucic S, Sanchez Menoyo JL, Cristiano E, Barnett MH, Hodgkinson S, Olascoaga J, Saladino ML, Gray O, Shaw C, Moore F, Butzkueven H, Kalincik T, Group MSS. Defining secondary progressive multiple sclerosis. Brain. 2016;139(Pt 9):2395–405. https://​doi.​org/​10.​1093/​brain/​aww173.CrossRefPubMed
21.
Zurück zum Zitat Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sorensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O’Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stuve O, Waubant E, Polman CH. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278–86. https://doi.org/10.1212/WNL.0000000000000560.CrossRefPubMedPubMedCentral Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sorensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O’Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stuve O, Waubant E, Polman CH. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278–86. https://​doi.​org/​10.​1212/​WNL.​0000000000000560​.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Jafari Z, Shahbodaghi MR, Maroufizadeh S, Moghadasi AN. Validation of the Persian version of dysphagia in multiple sclerosis questionnaire for the assessment of dysphagia in multiple sclerosis. Iran J Neurol. 2018;17(3):99–104.PubMedPubMedCentral Jafari Z, Shahbodaghi MR, Maroufizadeh S, Moghadasi AN. Validation of the Persian version of dysphagia in multiple sclerosis questionnaire for the assessment of dysphagia in multiple sclerosis. Iran J Neurol. 2018;17(3):99–104.PubMedPubMedCentral
24.
Zurück zum Zitat Field A. Discovering statistics using IBM SPSS statistics. 5th ed. London: SAGE Publications Ltd; 2017. Field A. Discovering statistics using IBM SPSS statistics. 5th ed. London: SAGE Publications Ltd; 2017.
25.
Zurück zum Zitat Lasemi E, Sahraian MA, Kalantar Motamedi MH, Valayi N, Moradi N, Lasemi R. Prevalence of oral and maxillofacial manifestations in patients with multiple sclerosis. SRM J Res Dent Sci. 2011;8(1):20–6. Lasemi E, Sahraian MA, Kalantar Motamedi MH, Valayi N, Moradi N, Lasemi R. Prevalence of oral and maxillofacial manifestations in patients with multiple sclerosis. SRM J Res Dent Sci. 2011;8(1):20–6.
26.
Zurück zum Zitat Terre-Boliart R, Orient-Lopez F, Guevara-Espinosa D, Ramon-Rona S, Bernabeu-Guitart M, Clave-Civit P. Oropharyngeal dysphagia in patients with multiple sclerosis (in Spanish). Rev Neurol. 2004;39(8):707–10.PubMed Terre-Boliart R, Orient-Lopez F, Guevara-Espinosa D, Ramon-Rona S, Bernabeu-Guitart M, Clave-Civit P. Oropharyngeal dysphagia in patients with multiple sclerosis (in Spanish). Rev Neurol. 2004;39(8):707–10.PubMed
27.
Zurück zum Zitat Aghaz A, Alidad A, Hemmati E, Jadidi H, Ghelichi L. Prevalence of dysphagia in multiple sclerosis and its related factors: systematic review and meta-analysis. Iran J Neurol. 2018;17(4):180–8.PubMedPubMedCentral Aghaz A, Alidad A, Hemmati E, Jadidi H, Ghelichi L. Prevalence of dysphagia in multiple sclerosis and its related factors: systematic review and meta-analysis. Iran J Neurol. 2018;17(4):180–8.PubMedPubMedCentral
28.
Zurück zum Zitat Solaro C, Rezzani C, Trabucco E, Amato MP, Zipoli V, Portaccio E, Giannini M, Patti F, D’Amico E, Frau J, Lorefice L, Bonavita S, Della Corte M, Grasso MG, Finamore L, Ghezzi A, Annovazzi P, Rottoli M, Gasperini C, Restivo D, Maimone D, Rossi P, Stromillo ML, Bergamaschi R. Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). J Neurol Sci. 2013;331(1–2):94–7. https://doi.org/10.1016/j.jns.2013.05.020.CrossRefPubMed Solaro C, Rezzani C, Trabucco E, Amato MP, Zipoli V, Portaccio E, Giannini M, Patti F, D’Amico E, Frau J, Lorefice L, Bonavita S, Della Corte M, Grasso MG, Finamore L, Ghezzi A, Annovazzi P, Rottoli M, Gasperini C, Restivo D, Maimone D, Rossi P, Stromillo ML, Bergamaschi R. Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). J Neurol Sci. 2013;331(1–2):94–7. https://​doi.​org/​10.​1016/​j.​jns.​2013.​05.​020.CrossRefPubMed
31.
Zurück zum Zitat Tarameshlu M, Azimi AR, Ghelichi L, Ansari NN. Prevalence and predictors of dysphagia in Iranian patients with multiple sclerosis. Med J Islam Repub Iran. 2017;31:133.CrossRef Tarameshlu M, Azimi AR, Ghelichi L, Ansari NN. Prevalence and predictors of dysphagia in Iranian patients with multiple sclerosis. Med J Islam Repub Iran. 2017;31:133.CrossRef
32.
Zurück zum Zitat Calcagno P, Ruoppolo G, Grasso M, De Vincentiis M, Paolucci S. Dysphagia in multiple sclerosis–prevalence and prognostic factors. Acta Neurol Scand. 2002;105(1):40–3.CrossRef Calcagno P, Ruoppolo G, Grasso M, De Vincentiis M, Paolucci S. Dysphagia in multiple sclerosis–prevalence and prognostic factors. Acta Neurol Scand. 2002;105(1):40–3.CrossRef
37.
Zurück zum Zitat Sasegbon A, Watanabe M, Simons A, Michou E, Vasant DH, Magara J, Bath PM, Rothwell J, Inoue M, Hamdy S. Cerebellar repetitive transcranial magnetic stimulation restores pharyngeal brain activity and swallowing behaviour after disruption by a cortical virtual lesion. J Physiol. 2019;597(9):2533–46.CrossRef Sasegbon A, Watanabe M, Simons A, Michou E, Vasant DH, Magara J, Bath PM, Rothwell J, Inoue M, Hamdy S. Cerebellar repetitive transcranial magnetic stimulation restores pharyngeal brain activity and swallowing behaviour after disruption by a cortical virtual lesion. J Physiol. 2019;597(9):2533–46.CrossRef
38.
Zurück zum Zitat Vasant DH, Sasegbon A, Michou E, Smith C, Hamdy S. Rapid improvement in brain and swallowing behavior induced by cerebellar repetitive transcranial magnetic stimulation in poststroke dysphagia: a single patient case-controlled study. Neurogastroenterol Motil. 2019;31(7):e13609.CrossRef Vasant DH, Sasegbon A, Michou E, Smith C, Hamdy S. Rapid improvement in brain and swallowing behavior induced by cerebellar repetitive transcranial magnetic stimulation in poststroke dysphagia: a single patient case-controlled study. Neurogastroenterol Motil. 2019;31(7):e13609.CrossRef
44.
Zurück zum Zitat Giraldo-Cadavid LF, Leal-Leaño LR, Leon-Basantes GA, Bastidas AR, Garcia R, Ovalle S, Abondano-Garavito JE. Accuracy of endoscopic and videofluoroscopic evaluations of swallowing for oropharyngeal dysphagia. Laryngoscope. 2017;127(9):2002–10.CrossRef Giraldo-Cadavid LF, Leal-Leaño LR, Leon-Basantes GA, Bastidas AR, Garcia R, Ovalle S, Abondano-Garavito JE. Accuracy of endoscopic and videofluoroscopic evaluations of swallowing for oropharyngeal dysphagia. Laryngoscope. 2017;127(9):2002–10.CrossRef
45.
Zurück zum Zitat Langmore SE. History of fiberoptic endoscopic evaluation of swallowing for evaluation and management of pharyngeal dysphagia: changes over the years. Dysphagia. 2017;32(1):27–38.CrossRef Langmore SE. History of fiberoptic endoscopic evaluation of swallowing for evaluation and management of pharyngeal dysphagia: changes over the years. Dysphagia. 2017;32(1):27–38.CrossRef
Metadaten
Titel
Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis
verfasst von
Mahdi Barzegar
Omid Mirmosayeb
Mina Rezaei
Geir Bjørklund
Nasim Nehzat
Alireza Afshari-Safavi
Vahid Shaygannejad
Publikationsdatum
12.02.2021
Verlag
Springer US
Erschienen in
Dysphagia / Ausgabe 1/2022
Print ISSN: 0179-051X
Elektronische ISSN: 1432-0460
DOI
https://doi.org/10.1007/s00455-021-10245-z

Weitere Artikel der Ausgabe 1/2022

Dysphagia 1/2022 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.